MIST Earnings & Financial Statements
Milestone Pharmaceuticals Inc.
$0.79
-$0.00(-0.36%)
27
Overall
--
Value
27
Tech
28
Quality
Market Cap
$98.09M
Volume
381.58K
52W Range
$0.71 - $3.06
Target Price
$5.86
MIST earnings and financial statements: Milestone Pharmaceuticals Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
MIST Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.55M | - | $1.00M | $5.00M | - |
| Operating income | -$62.14M | -$42.10M | -$61.10M | -$59.64M | -$43.07M |
| EBITDA | -$61.02M | -$37.44M | -$57.04M | -$58.30M | -$42.98M |
| Net income | -$63.06M | -$41.52M | -$59.69M | -$58.39M | -$42.85M |
| EPS (diluted) | $-0.75 | $-0.67 | $-1.39 | $-1.38 | $-1.02 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $113.56M | $75.50M | $75.23M | $74.48M | $119.85M |
| Total liabilities | $71.79M | $62.35M | $58.45M | $8.13M | $7.25M |
| Shareholders’ equity | $41.77M | $13.15M | $16.77M | $66.35M | $112.60M |
| Cash and equivalents | $73.05M | $25.31M | $13.76M | $7.64M | $114.14M |
| Long-term debt | $57.73M | $54.23M | $51.23M | $2.00M | $474.0K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$49.04M | -$28.85M | -$46.42M | -$52.47M | -$33.22M |
| Capital expenditure | -$302.0K | -$33.0K | -$112.0K | -$272.0K | - |
| Free cash flow | -$49.34M | -$28.88M | -$46.54M | -$52.74M | -$33.22M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MIST | $0.79 | -0.4% | 381.58K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Milestone Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW